PATENT CLAIM ANALYSIS

Application Number: 15875727
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "049000"]

Abstract:
Embodiments of compositions and methods for the treatment of blood disorders and malignancies in a subject are described herein. In one embodiment, a composition for the treatment of a blood disorder or a malignancy in a subject comprises decitabine, tetrahydrouridine, and an excipient. In another embodiment, a method for the treatment of a blood disorder or a malignancy in a subject comprises the oral administration of a composition comprising decitabine and tetrahydrouridine. In some examples, the composition may be administered 1-3 times weekly.

Claim (Index 8):
The composition of  claim 7 , wherein the blood disorder is a hemoglobinopathy or a thalassemia.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 2.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13414546', '15044805', '13141669', '12963490', '12252961']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.790419097468348
- 35 USC 102 Novelty (BERT): 0.6695492698054519
- Combined Prediction Score: 0.7783321147020584
- Mean Citation Score: 503.03080400000016
- Max Citation Score: 730.64197
- Similarity Product: 627.1664217427135

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test